PHS
Pekin Hardy Strauss’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,170
| Closed | -$30.2K | – | 371 |
|
|
2024
Q3 | $30.2K | Sell |
15,170
-10,000
| -40% | -$19.9K | ﹤0.01% | 337 |
|
|
2024
Q2 | $88.1K | Sell |
25,170
-6,000
| -19% | -$21K | 0.01% | 315 |
|
|
2024
Q1 | $86.3K | Sell |
31,170
-5,300
| -15% | -$14.7K | 0.01% | 314 |
|
|
2023
Q4 | $62K | Sell |
36,470
-22,625
| -38% | -$38.5K | 0.01% | 293 |
|
|
2023
Q3 | $60.9K | Sell |
59,095
-47,050
| -44% | -$48.5K | 0.01% | 298 |
|
|
2023
Q2 | $123K | Sell |
106,145
-465,560
| -81% | -$540K | 0.01% | 291 |
|
|
2023
Q1 | $863K | Sell |
571,705
-150
| -0% | -$227 | 0.12% | 152 |
|
|
2022
Q4 | $1.43M | Sell |
571,855
-71,260
| -11% | -$178K | 0.2% | 111 |
|
|
2022
Q3 | $2.71M | Buy |
643,115
+2,275
| +0.4% | +$9.6K | 0.43% | 63 |
|
|
2022
Q2 | $1.79M | Buy |
640,840
+42,575
| +7% | +$119K | 0.25% | 93 |
|
|
2022
Q1 | $3.42M | Buy |
598,265
+28,025
| +5% | +$160K | 0.43% | 58 |
|
|
2021
Q4 | $5.21M | Buy |
570,240
+126,855
| +29% | +$1.16M | 0.7% | 37 |
|
|
2021
Q3 | $4.74M | Sell |
443,385
-333,315
| -43% | -$3.56M | 0.68% | 35 |
|
|
2021
Q2 | $12.1M | Buy |
776,700
+255,895
| +49% | +$3.97M | 1.68% | 8 |
|
|
2021
Q1 | $8.44M | Buy |
520,805
+54,368
| +12% | +$881K | 1.33% | 18 |
|
|
2020
Q4 | $9.87M | Sell |
466,437
-128,476
| -22% | -$2.72M | 1.71% | 8 |
|
|
2020
Q3 | $8.82M | Buy |
594,913
+142
| +0% | +$2.11K | 1.8% | 9 |
|
|
2020
Q2 | $8.75M | Buy |
594,771
+6,039
| +1% | +$88.8K | 1.93% | 10 |
|
|
2020
Q1 | $6.91M | Buy |
588,732
+98,772
| +20% | +$1.16M | 1.55% | 14 |
|
|
2019
Q4 | $11.5M | Buy |
+489,960
| New | +$11.5M | 1.89% | 13 |
|